AUG 21 - 22 2013
Genetics and Genomics 2013
10679 45 132772

The theme of this conference is a range of genetics and genomics topics such as RNAi, Next-generation sequencing, Cancer research, Sequencing, Genome-wide association studies GWAS, Epigenetics, Mapping, Exomes, Genomic medicine, Human Genome Structural Variation, Pharmacogenetics, DNA/RNA Purification, Mutations, Translational Genomics, Bioinformatics, Genotyping, Pharmacogenomics, Screening, Cloning, Gene Expression, Phenotyping, Transcription, Functional Genomics, Synthetic Biology, Genome Engineering, Immunology, qPCR/Real-Time PCR, PCR, Biomarkers, Stem Cell research, Human Identification, Bioproduction, Molecular Diagnostics and much more. Attendees can earn free CME and CEU Credits.

This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in genetics and genomics. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

With the advent of genetic and genomic medicine, health care providers will benefit from attending this conference and gain knowledge including the understanding of genetic testing, how to calculate risk and when to refer a patient to a genetic specialist, how the application of genomics will be key to effective prevention and management of many of the most important health-care issues. They will learn skills including the ability to communicate genetic information, how to manage family dynamics, become up to date on tools that are available to help the health-care professionals convey complex genetic information to patients.

This program will help to convey to health care practitioners that genetics and genomics are qualitatively different from all other topics because it underlies all of pathophysiology, and is therefore the fundamental science of health and disease.

Conference participants will be able to:
 

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers
  • Earn free CME and CEU continuing educationn credits


No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.


Speakers:
  • Chief of Scientific Intelligence, Director of Molecular Oncology, John Wayne Cancer Institute
  • Associate Professor (Clinical) of Pathology, Division Medical Director, Genetics, Co-Program Director, Clinical Genetics Fellowship Program, Program Director, Molecular Genetics Fellowship Pr
  • Director Bioinformatics, Children's Hospital of Philadelphia, University of Pennsylvania
  • Director of Social Sciences & Bioethics, Assistant Professor, Scripps Translational Science Institute, Scripps Health & The Scripps Research Institute
  • CEO, CSO and Co-Founder, AllSeq, Inc.
  • Assistant Professor of Bioengineering at Stanford,  and President of The BioBricks Foundation
  • Chief Scientific Officer, AugureX Life Sciences Corp
  • Assistant Professor, Assistant Investigator, Abramson Family Cancer Research Institute, University of Pennsylvania Medicine
  • Professor of Laboratory Medicine, Mayo Clinic
  • Head of Molecular Microbiology Unit- Molecular Biology, Jewish General Hospital - McGill University
  • Head, Fungal Genomics Program, US Department of Energy Joint Genome Institute
  • Program director for FarGen, Faroe Islands Ministry of Health
  • Senior Manager, NGS Applications, DNASTAR
  • Investigator, Howard Hughes Medical Institute, Professor of Biochemistry, Adjunct Professor of Genome Sciences, Physics, Computer Science, Chemical Engineering, and Bioengineering, University
  • Professor, Cancer & Stem Cell Biology Pgm, Duke-NUS Graduate Medical School Singapore, Sr. Group Leader, Genome Institute of Singapore, Program Leader, Genomic Oncology, Cancer Science In
  • Director, Division of Genomic Technologies, RIKEN Center for Life Science Technologies
  • Associate Director for Science and Technology, Office of In Vitro Diagnostics and Radiological Health (OIR), CDRH, U.S. Food and Drug  Administration
  • Founder, President, CEO, TED Fellow, Rare Genomics Institute Washington University in St. Louis
  • Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
  • Chief Medical Officer, Life Technologies
  • Principle Investigator, Genome Laboratory, Tel Aviv University
  • Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
  • Associate Professor, Department of Pathology, University of Utah, Medical Director, Molecular Genetics and Genomics ARUP Laboratories
  • Founding Director of the Personalized Medicine Program and Human and Molecular Genetics Center, Warren P. Knowles Chair of Genetics, Professor, Department of Physiology & Pediatrics, Medi
  • Clinical Chemistry Postdoctoral Fellow, University of Chicago
  • Executive Director, Garvan Institute of Medical Research, Conjoint Professor in the St Vincent's Hospital Clinical School and the Faculty of Medicine, at the University of New South Wale
  • Head of Clinical Genomics, Garvan Institute of Medical Research, Conjoint Associate Professor at the University of New South Wales
  • Professor, Director, Infectious Diseases Program, J. Craig Venter Institute (JCVI)
  • Professor and Chair, Department of Genetics, Director, Heflin Center for Genomic Sciences, UAB
  • Assistant Professor in the Department of Pathology, Research Scientist, Memorial Sloan-Kettering Cancer Center
  • Professor and Chair, Genetics, Director, Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine
  • Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
  • Co-director, Pharmacogenomics and Genetics Laboratory, Co-director, Cardiovascular Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic
  • Instructor of Pathology, BWH and Harvard Medical School,  Assistant Laboratory Director and Senior IS Domain Specialist Laboratory for Molecular Medicine, Partners HealthCare Center for Perso
  • Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School
  • Distinguished Research Scientist, Autodesk Inc., Faculty, Singularity University
  • Laboratory Director, TessArae, LLC
  • Alisa Jackson, Moderator, Beckman Coulter, Inc. Zach Smith, MS, Project Scientist,  The Center for Genomics and Bioinformatics, Indiana University Mary Blair, Senior Application Scientist,
  • Chief Scientific Officer, Sequenom
  • Principal Investigator, Andria and Paul Heafy Family Fellow, MIT Whitehead Institute for Biomedical Research
  • Assistant Professor, Department of Systems & Computational Biology, Assistant Professor, Department of Epidemiology & Population Health, Albert Einstein College of Medicine
  • Assistant Professor at the University of Massachusetts Medical School, Program Chair for the Bioinformatics Program, Instructor in the Rabb School of Continuing Studies, Division of Graduate
  • Chief Scientific Officer, CardioDx, Inc.
  • Chief Executive Officer, Claritas Genomics
  • Director, Institute for Aging Research, Ingeborg and Ira Leon Rennert Chair in Aging Research, Professor, Department of Medicine (Endocrinology), Professor, Department of Genetics, Albert Ein
  • Director of Molecular BiologyResearch, Reproductive Medicine Associatesof New Jersey, Associate Professor, Department of Obstetrics, Gynecology,and Reproductive Sciences, UMDNJ-Robert Wood Jo
  • CEO and Founder, IncellDx Inc
  • Associate Professor of Neurobiology, Scripps Institute
  • Assistant Professor, Primary Faculty for the Program in Genomics and Ethics, Medical College of Wisconsin
  • President, Chief Executive Officer and Chief Scientific Officer, Professor of Medicine, Director, Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute
  • Professor, Department of Pathology, Associate Director, Clinical Pathology Laboratories, University of Michigan Health System

Show Resources
Agenda
All times are Pacific Time
  • AUG 21, 2013 06:00 AM PDT
    Speaker: David F Keren, MD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 06:00 AM PDT
    Speaker: Agnieszka Lichanska, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 06:00 AM PDT
    Speaker: Andrew Hessel, MSc
  • AUG 21, 2013 07:00 AM PDT
    Speaker: George Church, PhD
  • AUG 21, 2013 08:00 AM PDT
    Speaker: Linnea Baudhuin, PhD, DABMG
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 08:00 AM PDT
    Speaker: Matthew Lebo, PhD, FACMG
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 08:00 AM PDT
    Speaker: Christopher I Amos, PhD
  • AUG 21, 2013 09:00 AM PDT
    Speaker: Michael Snyder, PhD
  • AUG 21, 2013 10:00 AM PDT
    Speaker: William C Nierman, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 10:00 AM PDT
    Speaker: Michael F Berger, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 10:00 AM PDT
    Speaker: Bruce R Korf, MD, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 11:00 AM PDT
    Speaker: Alisa Jackson, Zach Smith, Mary Blair, Dave Delano
  • AUG 21, 2013 12:00 PM PDT
    Speaker: Robert Roberts, MD, FRCPC, MACC, LLD (Hon.)
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 12:00 PM PDT
    Speaker: Yaniv Erlich, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 12:00 PM PDT
    Speaker: Charles Cantor, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 01:00 PM PDT
    Speaker: Bruce K Patterson, MD
  • AUG 21, 2013 01:00 PM PDT
    Speaker: Vincent P Mauro, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 01:00 PM PDT
    Speaker: Kimberly Strong, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 02:00 PM PDT
    Speaker: Patrice Milos, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 02:00 PM PDT
    Speaker: Nathan R Treff, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 02:00 PM PDT
    Speaker: Nir Barzilai, MD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 03:00 PM PDT
    Speaker: Steven Rosenberg, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 03:00 PM PDT
    Speaker: Daniel Caffrey, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 03:00 PM PDT
    Speaker: Jessica C Mar, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 04:00 PM PDT
    Speaker: Edward Ki Yun Leung, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 04:00 PM PDT
    Speaker: Marcel Dinger, MSc (hons), PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 04:00 PM PDT
    Speaker: John Mattick, PhD,AO, FAA, FRCPA
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 05:00 PM PDT
    Speaker: Igor Grigoriev, PhD
  • AUG 21, 2013 05:00 PM PDT
    Speaker: Ivan Brukner, PhD
  • AUG 22, 2013 07:00 AM PDT
    Speaker: Kathryn E Wellen, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 07:00 AM PDT
    Speaker: Anthony Marotta, PhD
  • AUG 22, 2013 07:00 AM PDT
    Speaker: Thomas P Moyer, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 08:00 AM PDT
    Speaker: Drew Endy, PhD
  • AUG 22, 2013 09:00 AM PDT
    Speaker: Deanne Taylor, MS, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 09:00 AM PDT
    Speaker: Shawn Baker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 09:00 AM PDT
    Speaker: Cinnamon S Bloss, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 10:00 AM PDT
    Speaker: Elaine Lyon, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 10:00 AM PDT
    Speaker: Bogi Eliasen, MSc
  • AUG 22, 2013 10:00 AM PDT
    Speaker: Matthew Keyser, MS
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 11:00 AM PDT
    Speaker: David Baker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 12:00 PM PDT
    Speaker: Pinar Bayrak-Toydemir, MD, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 12:00 PM PDT
    Speaker: Howard J Jacob, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 01:00 PM PDT
    Speaker: Noam Shomron, PhD
  • AUG 22, 2013 01:00 PM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
  • AUG 22, 2013 02:00 PM PDT
    Speaker: John Quackenbush, PhD
  • AUG 22, 2013 02:00 PM PDT
    Speaker: Paul Billings, MD, PhD
  • AUG 22, 2013 03:00 PM PDT
    Speaker: Živana Težak, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 03:00 PM PDT
    Speaker: C Jimmy Lin, MD, PhD, MHS
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 04:00 PM PDT
    Speaker: Piero Carninci, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 05:00 PM PDT
    Speaker: Dave S Hoon, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 05:00 PM PDT
    Speaker: Patrick Tan, MD, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 06:00 AM PDT
    Speaker: David F Keren, MD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 06:00 AM PDT
    Speaker: Agnieszka Lichanska, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 06:00 AM PDT
    Speaker: Andrew Hessel, MSc
  • AUG 21, 2013 07:00 AM PDT
    Speaker: George Church, PhD
  • AUG 21, 2013 08:00 AM PDT
    Speaker: Linnea Baudhuin, PhD, DABMG
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 08:00 AM PDT
    Speaker: Matthew Lebo, PhD, FACMG
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 08:00 AM PDT
    Speaker: Christopher I Amos, PhD
  • AUG 21, 2013 09:00 AM PDT
    Speaker: Michael Snyder, PhD
  • AUG 21, 2013 10:00 AM PDT
    Speaker: William C Nierman, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 10:00 AM PDT
    Speaker: Michael F Berger, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 10:00 AM PDT
    Speaker: Bruce R Korf, MD, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 11:00 AM PDT
    Speaker: Alisa Jackson, Zach Smith, Mary Blair, Dave Delano
  • AUG 21, 2013 12:00 PM PDT
    Speaker: Robert Roberts, MD, FRCPC, MACC, LLD (Hon.)
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 12:00 PM PDT
    Speaker: Yaniv Erlich, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 12:00 PM PDT
    Speaker: Charles Cantor, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 01:00 PM PDT
    Speaker: Bruce K Patterson, MD
  • AUG 21, 2013 01:00 PM PDT
    Speaker: Vincent P Mauro, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 01:00 PM PDT
    Speaker: Kimberly Strong, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 02:00 PM PDT
    Speaker: Patrice Milos, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 02:00 PM PDT
    Speaker: Nathan R Treff, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 02:00 PM PDT
    Speaker: Nir Barzilai, MD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 03:00 PM PDT
    Speaker: Steven Rosenberg, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 03:00 PM PDT
    Speaker: Daniel Caffrey, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 03:00 PM PDT
    Speaker: Jessica C Mar, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 04:00 PM PDT
    Speaker: Edward Ki Yun Leung, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 04:00 PM PDT
    Speaker: Marcel Dinger, MSc (hons), PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 04:00 PM PDT
    Speaker: John Mattick, PhD,AO, FAA, FRCPA
    SEE ABSTRACT | Continuing Education: CE
  • AUG 21, 2013 05:00 PM PDT
    Speaker: Igor Grigoriev, PhD
  • AUG 21, 2013 05:00 PM PDT
    Speaker: Ivan Brukner, PhD
  • AUG 22, 2013 07:00 AM PDT
    Speaker: Kathryn E Wellen, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 07:00 AM PDT
    Speaker: Anthony Marotta, PhD
  • AUG 22, 2013 07:00 AM PDT
    Speaker: Thomas P Moyer, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 08:00 AM PDT
    Speaker: Drew Endy, PhD
  • AUG 22, 2013 09:00 AM PDT
    Speaker: Deanne Taylor, MS, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 09:00 AM PDT
    Speaker: Shawn Baker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 09:00 AM PDT
    Speaker: Cinnamon S Bloss, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 10:00 AM PDT
    Speaker: Elaine Lyon, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 10:00 AM PDT
    Speaker: Bogi Eliasen, MSc
  • AUG 22, 2013 10:00 AM PDT
    Speaker: Matthew Keyser, MS
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 11:00 AM PDT
    Speaker: David Baker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 12:00 PM PDT
    Speaker: Pinar Bayrak-Toydemir, MD, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 12:00 PM PDT
    Speaker: Howard J Jacob, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 01:00 PM PDT
    Speaker: Noam Shomron, PhD
  • AUG 22, 2013 01:00 PM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
  • AUG 22, 2013 02:00 PM PDT
    Speaker: John Quackenbush, PhD
  • AUG 22, 2013 02:00 PM PDT
    Speaker: Paul Billings, MD, PhD
  • AUG 22, 2013 03:00 PM PDT
    Speaker: Živana Težak, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 03:00 PM PDT
    Speaker: C Jimmy Lin, MD, PhD, MHS
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 04:00 PM PDT
    Speaker: Piero Carninci, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 05:00 PM PDT
    Speaker: Dave S Hoon, PhD
    SEE ABSTRACT | Continuing Education: CE
  • AUG 22, 2013 05:00 PM PDT
    Speaker: Patrick Tan, MD, PhD
    SEE ABSTRACT | Continuing Education: CE
Speakers

  • Dave S Hoon, PhD
    Chief of Scientific Intelligence, Director of Molecular Oncology, John Wayne Cancer Institute
  • Elaine Lyon, PhD
    Associate Professor (Clinical) of Pathology, Division Medical Director, Genetics, Co-Program Director, Clinical Genetics Fellowship Program, Program Director, Molecular Genetics Fellowship Pr
    Biography
      Dr. Lyon is the medical director of the Genetics Division, co-medical director of Pharmacogenomics, and co-director of the Molecular Genetics Fellowship Program at ARUP, and an associate professor of pathology at the University of Utah School of Medicine. She received her PhD in medical genetics from the University of Alabama at Birmingham and continued with fellowship training in clinical molecular genetics at the University of Utah. Dr. Lyon combines clinical laboratory responsibilities with research and development in human genetics, employing methods for mutation detection by targeted mutation analysis, gene sequencing, gene scanning, exonic-level deletion, and duplications and molecular haplotyping. Dr. Lyon has focused her interest in studies to determine the significance of rare variants and is involved with evaluating and establishing locus-specific databases that combine genetic variants with clinical symptoms.
    • Deanne Taylor, MS, PhD
      Director Bioinformatics, Children's Hospital of Philadelphia, University of Pennsylvania
      Biography
        Deanne Taylor joined DBHI in 2014 as the Bioinformatics Director. Deanne oversees the design, development, and implementation of high performance innovative bioinformatics workflows and provide technical leadership and supervision of a multidisciplinary bioinformatics team at CHOP. Previously, she was Director of Bioinformatics with Reproductive Medicine Associates and Assistant Professor with the Department of Obstetrics, Gynecology and Reproductive Medicine at Rutgers Robert Wood Johnson Medical School. Prior to that she worked for Harvard School of Public Health as a Research Scientist and served several years as the Program Director of the Graduate Program in Bioinformatics at Brandeis University. She also has experience working in the pharmaceutical industry. Deanne obtained her PhD in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral fellowship at Pfizer. Her background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. Deanne's main areas of research are in the development of mathematical and computational methods to better understand biological variation and the genetic contribution to disease, coupling clinical information with high-dimensional biomedical data from next-gen sequencing, microarray, PCR, and proteomics experiments.
      • Cinnamon S Bloss, PhD
        Director of Social Sciences & Bioethics, Assistant Professor, Scripps Translational Science Institute, Scripps Health & The Scripps Research Institute
        Biography
          Dr. Bloss is an Assistant Professor, as well as Director of Social Sciences and Bioethics at the Scripps Translational Science Institute. Her research is funded by the National Institutes of Health and is focused on investigating individuals' behavioral and psychological responses to disclosure of personal genomic information. She is the lead researcher on STSI's Scripps Genomic Health Initiative, and her work on this project was recently published in the New England Journal of Medicine and has been highlighted at a number of national and international scientific meetings. She has also presented invited testimony on consumer genomics before the Food and Drug Administration Advisory Panel.   Dr. Bloss' other research interests include developing ways of combining genomics with traditional disease risk factors to make predictions about disease development, progression and response to treatment, as well as designing effective health interventions that leverage genomic information. She also conducts genetic association studies and has several collaborations to investigate the genetic underpinnings of neurological, behavioral, and other health-related phenotypes.   Dr. Bloss received her B.A. in Psychology from Smith College, her Ph.D. in Clinical Psychology from the University of California, San Diego, and completed a predoctoral internship in clinical neuropsychology at the University of Florida. Dr. Bloss completed a post-doctoral fellowship in statistical genetics and genomic medicine at The Scripps Research Institute.
        • Shawn Baker, PhD
          CEO, CSO and Co-Founder, AllSeq, Inc.
          Biography
            Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench developing gene expression array products, he transitioned to Product Marketing where he led a team in charge of Illuminas Expression and Regulation sequencing portfolio. In 2013 Dr. Baker co-founded AllSeq, establishing the only true sequencing marketplace, matching researchers with service providers based on their needs. <br />
          • Drew Endy, PhD
            Assistant Professor of Bioengineering at Stanford,  and President of The BioBricks Foundation
            Biography
              Drew Endy developed the world's first "fabless" genetic engineering teaching lab in the new Bioengineering program at Stanford and previously helped start the Biological Engineering major at MIT. His Stanford research team develops genetically encoded computers and redesigns genomes. He co-founded the BioBricks Foundation as a public-benefit charity supporting free-to-use standards and technology that enable the engineering of biology. He co-organized the International Genetically Engineered Machines (iGEM.org) competition, the BIOFAB International Open Facility Advancing Biotechnology (BIOFAB.org), and Gen9, Inc. (Gen9bio.com). He serves on the US Committee on Science Technology and Law and is a new voting member of the US National Science Advisory Board for Biosecurity. He chaired the 2003 Synthetic Biology study as a member of DARPA ISAT, served as an ad hoc member of the US NIH Recombinant DNA Advisor Committee, and co-authored the 2007 "Synthetic Genomics: Options for Governance" report with colleagues from the Center for Strategic & International Studies and the J. Craig Venter Institute. Esquire named Endy one of the 75 most influential people of the 21st century. He lives in Menlo Park CA with his wife and Stanford Bioengineering colleague Prof. Christina Smolke.
            • Anthony Marotta, PhD
              Chief Scientific Officer, AugureX Life Sciences Corp
              Biography
                Anthony serves as the Chief Scientific Officer at Augurex Life Sciences Corp, a company that he co-founded with CEO, Mrs. Norma Biln. Anthony's creativity and business acumen have set him apart from most scientific leaders. Anthony has worked in the life sciences space for 20 years and has consistently created progressive opportunities that have delivered great returns for companies that he has been involved with. He received his PhD from the Faculty of Medicine at the University of British Columbia in Vancouver, Canada.
              • Kathryn E Wellen, PhD
                Assistant Professor, Assistant Investigator, Abramson Family Cancer Research Institute, University of Pennsylvania Medicine
                Biography
                  Dr. Kathryn Wellen received a PhD from Harvard University in 2006 and performed postdoctoral work at the University of Pennsylvania from 2006-2011. In 2011 she joined the Department of Cancer Biology at the University of Pennsylvania as an Assistant Professor. She is a 2012 Pew Scholar in the Biomedical Sciences and is a recipient of a 2012 Forbeck Scholar Award. Her laboratory's research focuses on elucidating links between cellular metabolism and signaling, with a current emphasis on metabolic regulation of the epigenome.
                • Thomas P Moyer, PhD
                  Professor of Laboratory Medicine, Mayo Clinic
                  Biography
                    Thomas P Moyer received a BA in Chemistry from the University of Minnesota in 1970. Following receipt of his undergraduate degree he spent two years in the United State Army Infantry. Upon completing his military service, Moyer entered graduate school at North Dakota State University where he earned the PhD degree in Biochemistry in 1976. He trained at Mayo Clinic as a Fellow in Clinical Chemistry, and joined the medical staff of Mayo Clinic in Rochester, Minnesota in 1979 as a Consultant in the Department of Laboratory Medicine & Pathology. While at Mayo Clinic, Moyer created the Drug Laboratory and lead in the formation of the Nucleotide Polymorphism Laboratory. He was Division Chair of Clinical Biochemistry & Immunology, and served as Vice Chair of the Department of Laboratory Medicine & Pathology and as Senior Vice President of Mayo Medical Laboratories. Dr. Moyer was elected by the medical staff to serve as an Officer of Mayo Clinic in 2000. He has published 108 peer reviewed papers, 123 abstracts, 30 book chapters, and two books. Dr Moyer was also active in the American Association for Clinical Chemistry (AACC) serving in numerous leadership roles, including as President in 2004. He also represented AACC to the International Federation of Clinical Chemistry, serving as a member of the Scientific Division, and a member of the Congress and Conference Division.
                  • Ivan Brukner, PhD
                    Head of Molecular Microbiology Unit- Molecular Biology, Jewish General Hospital - McGill University
                  • Igor Grigoriev, PhD
                    Head, Fungal Genomics Program, US Department of Energy Joint Genome Institute
                    Biography
                      Dr. Grigoriev joined the DOE Joint Genome Institute in 2003 to participate in human genome annotation and lead annotation of over 200 diverse eukaryotic genomes from protists to plants (http://genome.jgi.doe.gov). In 2009 at JGI he started the Fungal Genomics program (http://www.jgi.doe.gov/fungi) to scale up sequencing and analysis of diverse fungi for related to DOE science and applications, which led to large projects like 1000 Fungal Genomes. Dr. Grigoriev organized over 30 genomics workshops and engaged over 2000 researches around the world in genome projects, which resulted in over 50 high-profile publications.
                    • Bogi Eliasen, MSc
                      Program director for FarGen, Faroe Islands Ministry of Health
                      Biography
                        Bogi Eliasen is a knowledge-broker bringing the expertise of all kinds of disciplines together. He is an expert on international politics and law and manages the first nationwide genome sequencing project in the world, FarGen.
                      • Matthew Keyser, MS
                        Senior Manager, NGS Applications, DNASTAR
                        Biography
                          Matthew Keyser is Senior Manager, NGS Applications for DNASTAR, where he has helped scientists address their sequence assembly and analysis challenges for the past seven years. Matts sole focus at DNASTAR is supporting customers in next-gen sequencing applications using DNASTARs broad software toolset. Matt helps customers with their templated and de novo assembly projects, transcriptomes, exomes, metagenomic assemblies, RNA-Seq, ChIP-Seq and numerous other unique experiments. Matt has helped hundreds of scientists optimize their workflows using DNASTARs next-gen software solutions. He has also spoken at numerous conferences and workshops regarding the capabilities of DNASTARs next-gen software tools.
                        • David Baker, PhD
                          Investigator, Howard Hughes Medical Institute, Professor of Biochemistry, Adjunct Professor of Genome Sciences, Physics, Computer Science, Chemical Engineering, and Bioengineering, University
                          Biography
                            The Baker laboratory developed the Rosetta algorithm for ab initio protein structure prediction, which has been extended to a distributed computing project called Rosetta@Home and Foldit. The project aims to produce structural models for protein complexes as well as individual polypeptide chains. The Baker group participates regularly and is recognized for expertise in the CASP structure prediction experiment using ab initio methods, including both manually assisted and automated variants of the Rosetta protocol. Members of the Baker group are also active in the field of protein design; they are recognized as the first group to have designed a protein, known as Top7, with an entirely novel fold. Baker did his graduate work in biochemistry at the University of California, Berkeley in the laboratory of Randy Schekman, where he worked predominantly on protein transport and trafficking in yeast. He did his postdoctoral work with David Agard of University of California, San Francisco. Although well known for development of methods for computational prediction of protein structure and function, Baker is focused on the use of computational methods to drive experimental assessment of biology and therefore the Baker laboratory maintains an active experimental biochemistry group. For his work on protein folding, Baker received the 2008 Sackler International Prize in Biophysics. Baker was elected a Fellow of the American Academy of Arts and Sciences in 2009.
                          • Patrick Tan, MD, PhD
                            Professor, Cancer &amp; Stem Cell Biology Pgm, Duke-NUS Graduate Medical School Singapore, Sr. Group Leader, Genome Institute of Singapore, Program Leader, Genomic Oncology, Cancer Science In
                            Biography
                              Dr. Patrick Tan holds a joint appointment as a Professor at the Duke-NUS Graduate Medical School and Senior Group Leader at the Genome Institute of Singapore. He is also Senior Principal Investigator at the Cancer Science Institute of Singapore, National University of Singapore and Research Associate Professor in the Institute of Genome Sciences and Policy at Duke University, USA. His research focuses on the application of genomics to cancer and infectious disease. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other honors include the President's Scholarship, Loke Cheng Kim foundation scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), Singhealth Investigator Excellence Award, Han-Mo Koo Memorial Lectureship (Van Andel Research Institute, USA) and Swee Liew Wadsworth Lectureship (NUS). Recently, he received the Chen New Investigator Award from the Human Genome Organization (HUGO), and was elected to the American Society for Clinical Investigation (ASCI). He is a member of the Bioethics Advisory Committee (BAC), a national body that provides advice to the Singapore government on ethical issues related to biomedical research.
                            • Piero Carninci, PhD
                              Director, Division of Genomic Technologies, RIKEN Center for Life Science Technologies
                              Biography
                                Born and Educated in Italy he obtained his doctoral degree at the University of Trieste in 1989. From 1990 to 1995 he developed technologies for DNA extraction and DNA sequencing at Talent, a spin-off biotech. He moved to Japan in 1995 at RIKEN, Tsukuba Life Science center and became tenure researcher in 1997. He has been developing technologies to capture full-length cDNAs, which were used for the construction of the Fantom projects. Between 2008 and 2013, he was a Team and Unit Leader and a Deputy Project Director at the RIKEN Omics Science Center in Yokohama. He has developed technologies to analyze the the transcribed part of the genome (transcriptome), such as the cap-trapper and the CAGE. These technologies have been broadly used in the RIKEN Fantom projects and allowed identifying non-coding RNAs as are the major output of the mammalian genome and providing comprehensive maps of the mammalian promoters. Additionally he developed a miniaturization of CAGE, in order to approach biological problems that for which there is limited amount of starting material. From April in 2013, he is a Director of the Division Genomics Technologies and a Deputy Director of Center for Life Science Technologies, RIKEN. He has published more than 200 papers and book chapters, edited books and is a member of editorial boards of various scientific journals.
                              • Živana Težak, PhD
                                Associate Director for Science and Technology, Office of In Vitro Diagnostics and Radiological Health (OIR), CDRH, U.S. Food and Drug  Administration
                                Biography
                                  Živana Težak, Ph.D., is an Associate Director for Science and Technology, Personalized Medicine Staff, in the Office of In Vitro Diagnostic Device (IVD) Evaluation and Safety (OIR), at the Center for Devices and Radiological Health, Food and Drug Administration (FDA). Prior to joining the FDA in 2004, as a scientific reviewer in microbiology, genomics and molecular biology, Dr. Težak worked in biotechnology industry, holding research and development scientist positions in a bioinformatics and array developer company. Dr. Težak received a Ph.D. in Biochemistry/Molecular Biology from Florida State University in 1997. From 1998 to 2001 she was a research fellow at the University of Pittsburgh Medical Center and Children's National Medical Center, Research Center for Genetic Medicine, working on neuromuscular disorders, human genetics, gene therapy, and high-throughput screening technologies. Her work resulted in a number of publications in peer-reviewed journals, book chapters and proceedings. In her current position, Dr. Težak has been leading efforts to develop flexible regulatory policies for novel technology based IVDs, such as chromosomal microarrays and next-generation sequencing, in order to enable their smoother translation into the clinic.
                                • C Jimmy Lin, MD, PhD, MHS
                                  Founder, President, CEO, TED Fellow, Rare Genomics Institute Washington University in St. Louis
                                  Biography
                                    Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical institutions, such as Harvard, Yale, Johns Hopkins, and Stanford, RGI helps custom design personalized research projects for diseases so rare that no organization exists to help. Dr. Lin is also a medical school faculty member at the Washington University in St. Louis and led the computational analysis of the first ever exome sequenching studies for any human disease at Johns Hopkins. He has numerous publications in Science, Nature, Cell, Nature Genetics, and Nature Biotechnology, and has been featured in Forbes, Bloomberg, Wall Street Journal, Washington Post, and the Huffington Post.
                                  • John Quackenbush, PhD
                                    Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
                                    Biography
                                      John Quackenbush received his PhD in theoretical physics from UCLA in 1990. Following a physics postdoc, he received a Special Emphasis Research Career Award from the National Center for Human Genome Research to work on the Human Genome Project, spending two years at the Salk Institute and two years at Stanford University working in genomics and computational biology. In 1997 he moved to The Institute for Genomic Research (TIGR), pioneering expression analysis. He joined the Dana-Farber Cancer Institute and the Harvard School of Public Health in 2005, and works reconstruction of gene networks that drive the development of diseases. In 2012 he and Mick Correll co-Founded GenoSpace, a company that develops software tools to enable precision medicine applications. <br />
                                    • Paul Billings, MD, PhD
                                      Chief Medical Officer, Life Technologies
                                      Biography
                                        Board certified internist and clinical geneticist Dr. Paul R. Billings serves as Chief Medical Officer, a new position aimed at improving patient care through expanding the use of medically relevant genomic technologies in clinical settings. Dr. Billings brings extensive expertise and clinical experience in the areas of genomics and molecular medicine. Most recently, he served as Director and Chief Scientific Officer of the Genomic Medicine Institute at El Camino Hospital, the largest community hospital in the Silicon Valley. He currently serves as a member of the United States Department of Health and Human Services Secretary's Advisory Committee on Genetics, Health and Society, where he helps shape policy in the rapidly evolving field of genomic medicine. Dr. Billings has had a distinguished career as a physician and researcher. He has been a founder or chief executive officer of companies involved in genetic and diagnostic medicine, including GeneSage, Omicia and CELLective Dx Corporation. Previously, he was senior vice president for corporate development at Laboratory Corporation of America Holdings (LabCorp). He has held academic appointments at some of the most prestigious universities in the United States, including Harvard Medical School, Stanford School of Medicine and the University of California, Berkeley, and has served as a physician at a number of medical centers throughout the country, including the University of California, San Francisco. He is the author of nearly 200 publications and books on genomic medicine. Dr. Billings holds an M.D. from Harvard Medical School and a Ph.D. in immunology, also from Harvard University.
                                      • Noam Shomron, PhD
                                        Principle Investigator, Genome Laboratory, Tel Aviv University
                                        Biography
                                          Dr. Noam Shomron heads a research team which focuses on the analysis of genomic sequences and gene expression aimed at understanding human diseases. Dr Shomron trained at Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) where he combined high-throughput methods with computational analysis. Dr Shomron joined Tel Aviv University's Medical School in October 2008. Dr Shomron's is highly skilled in deep (next generation) sequencing technologies, in addition to parsing and processing the sequencing output. His strength in the genomic world stems from his extensive experience and knowledge using state-of-the-art methods both experimentally and computationally. Dr Shomron's overall interest and goals lie within seeking a better understanding of the mechanisms leading to disease development. His team seeks innovative solutions to generate a significant impact through translating ideas into clinical reality. Dr Shomron is also the Director of Rare Genomics Institute's Israel branch; co-founder and Scientific Director of the Functional Genomics Laboratory at Tel Aviv University; Editor-in-Chief of ‘Genetics Research' (published by Cambridge University Press); Editor of ‘Deep Sequencing Data Analysis' (a ‘Methods in Molecular Biology' book series published by Springer/Humana Press), Academic Director of BioAbroad.
                                        • Kenneth Buetow, PhD, FACMI
                                          Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
                                          Biography
                                            Dr. Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. Dr. Buetow currently serves as Director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU) and is a professor in the School of Life Sciences in ASU's College of Liberal Arts and Sciences. CAS@ASU applies systems approaches that leverage ASU's interdisciplinary research strengths to address complex global challenges. The Computational Sciences and Informatics program is developing and applying information technology to collect, connect, and enhance trans-disciplinary knowledge both within ASU and across the broader knowledge-generating ecosystems. CAS@ASU is creating a Next Generation Cyber Capability to address the challenges and opportunities afforded by "Big Data" and the emergence of 4th Paradigm Data Science. This capability brings state-of-the-art computational approaches to CAS@ASU's transdisciplinary, use-inspired research efforts Dr. Buetow previously served as the Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health's National Cancer Institute (NCI). In that capacity he initiated and oversaw the NCI's efforts to connect the global cancer community through community-developed, standards-based, interoperable informatics capabilities that enable secure exchange and use of biomedical data. Buetow designed and built one of the largest biomedical computing efforts in the world. He was responsible for coordinating biomedical informatics and information technology at the NCI. The NCI center he led focused on speeding scientific discovery and facilitated translational research by coordinating, developing and deploying biomedical informatics systems, infrastructure, tools and data in support of NCI research initiatives.
                                          • Pinar Bayrak-Toydemir, MD, PhD
                                            Associate Professor, Department of Pathology, University of Utah, Medical Director, Molecular Genetics and Genomics ARUP Laboratories
                                            Biography
                                              Dr. Bayrak-Toydemir is a Medical Director of the Molecular Genetics and Genomics Laboratories at Associated Regional and University Pathologists (ARUP) Laboratories and an Associate Professor of Pathology at the University of Utah, School of Medicine. Dr. Bayrak-Toydemir received her MD from Ankara University School of Medicine in Ankara, Turkey, where she also received her PhD in Human Genetics. Subsequently, she completed her fellowship in Clinical Molecular Genetics at the University of Utah. She is board certified in clinical molecular genetics. Dr. Bayrak-Toydemir has a long term interest in identification of genes that cause various inherited vascular malformations. Specifically, she is interested in hereditary hemorrhagic telangiectasia, capillary malformation-arteriovenous malformation syndrome, and aortopathies. She has extensive experience on both the clinical and research applications of the next generation sequencing technology. Under her leadership Molecular Genetics Laboratory is able to offer a long list of gene panels and exome sequencing, and help to improve patient management in various disorders, by providing a comprehensive evaluation of the underlying genetic background.
                                            • Howard J Jacob, PhD
                                              Founding Director of the Personalized Medicine Program and Human and Molecular Genetics Center, Warren P. Knowles Chair of Genetics, Professor, Department of Physiology &amp; Pediatrics, Medi
                                            • Edward Ki Yun Leung, PhD
                                              Clinical Chemistry Postdoctoral Fellow, University of Chicago
                                              Biography
                                                Born and raised in Vancouver, British Columbia, Canada. I received my Bachelor of Science and my Doctor of Philosophy from the Department of Molecular Biology and Biochemistry at Simon Fraser University. I studied the photochemistry and reduction-oxidation chemistry of nucleic acids with Dr. Dipankar Sen. I was a postdoctoral fellow for three years with Dr. Joseph Piccirilli from the Department of Biochemistry and Molecular Biology at the University of Chicago and studied RNA structural biology using phage-display technology and crystallography. For the past two years, I am in the clinical chemistry postdoctoral fellow at the University of Chicago Medicine, a ComACC certified training program under the directorship of Dr. Jerry Yeo. My research interest is in personalized medicine. My research interest is in personalized medicine. I am interested in developing and using mass spectrometry to study an observed phenotype (ie. protein levels, protein post-translational modifications, and active drugs and/or its metabolites) and next-generation sequencing to study the corresponding genotype. By combining genetic and phenotypic data, a more well-rounded and complete understanding of personalized medicine can be achieved.
                                              • John Mattick, PhD,AO, FAA, FRCPA
                                                Executive Director, Garvan Institute of Medical Research, Conjoint Professor in the St Vincent's Hospital Clinical School and the Faculty of Medicine, at the University of New South Wale
                                                Biography
                                                  John joined the Garvan Institute as the Executive Director in January 2012. He has made a significant contribution to the understanding of genetics and genomics through his farsighted theories on 'junk' DNA, the large non-coding sections of the human genome that do not code for proteins. Most recently John was the Professor of Molecular Biology and NHMRC Australia Fellow at the Institute for Molecular Bioscience, University of Queensland. John was educated at St Patrick's College Strathfield, the University of Sydney and Monash University, where he obtained his PhD. He has subsequently worked at Baylor College of Medicine in Houston, the CSIRO Division of Molecular Biology in Sydney, and the University of Queensland, where he was based from 1988-2011. He has also spent research periods at the Universities of Cambridge, Oxford, Cologne and Strasbourg. He was Foundation Director of the Australian Genome Research Facility and the Institute for Molecular Bioscience.
                                                • Marcel Dinger, MSc (hons), PhD
                                                  Head of Clinical Genomics, Garvan Institute of Medical Research, Conjoint Associate Professor at the University of New South Wales
                                                  Biography
                                                    Marcel Dinger is the Head of Genome Informatics at the Garvan Institute of Medical Research and conjoint Associate Professor at UNSW Australia. After completing his PhD at the University of Waikato (New Zealand), he was awarded a NZ FoRST Postdoctoral Fellowship to join Professor Mattick's group at The University of Queensland to study the role of long noncoding RNAs in mammalian development and disease. He was recruited to the Garvan Institute in 2012.
                                                  • William C Nierman, PhD
                                                    Professor, Director, Infectious Diseases Program, J. Craig Venter Institute (JCVI)
                                                    Biography
                                                      Dr. William Nierman is the Director of the Infectious Disease Program at the J. Craig Venter Institute (JCVI). He is also a Professor the George Washington University School of Medicine and has taught Human Genetics at The Johns Hopkins University. He received his BS degree from the US Naval Academy and his PhD degree from the University of California, Berkeley. Dr. Nierman has broad experience in microbial pathogen genomics. His research focus is the genomic and functional analysis of two the levels of pathogen interaction with the human host, that caused by severe acute disease-causing bacterial pathogens, and that caused by fungi that can cause disease only in an immune-system-compromised host. Burkholderia mallei and Burkholderia pseudomallei are severe bacterial pathogens that cause difficult to diagnose but very life threatening diseases, glanders and melioidosis. At the other end of the pathogenicity scale are Aspergillus and Penicillium fungal pathogens which cause invasive or systemic disease in immune compromised or immune suppressed human hosts. Management of the disease in both classes of infections is becoming increasingly compromised by the rapid evolution of drug resistance in the pathogens. Both groups of organisms pose serious public health issues in both developed and in developing countries.
                                                    • Bruce R Korf, MD, PhD
                                                      Professor and Chair, Department of Genetics, Director, Heflin Center for Genomic Sciences, UAB
                                                      Biography
                                                        Dr. Korf is Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair of the Department of Genetics, Director of the Heflin Center for Genomic Sciences at UAB, and Co-Director of the UAB-HudsonAlpha Center for Genomic Medicine. He is a medical geneticist, pediatrician, and child neurologist, certified by the American Board of Medical Genetics (clinical genetics, clinical cytogenetics, clinical molecular genetics), American Board of Pediatrics, and American Board of Psychiatry and Neurology (child neurology). Dr. Korf is past president of the Association of Professors of Human and Medical Genetics, past president of the American College of Medical Genetics and Genomics, and current president of the ACMG Foundation for Genetic and Genomic Medicine. He has served on the Board of Scientific Counselors of the National Cancer Institute and the National Human Genome Research Institute at the NIH. He chairs the Medical Advisory Committee of the Children's Tumor Foundation and serves on the CTF Board of Directors. His major research interests are molecular diagnosis of genetic disorders and the natural history, genetics, and treatment of neurofibromatosis. He serves as principal investigator of the Department of Defense funded Neurofibromatosis Clinical Trials Consortium. He is co-author of Human Genetics and Genomics (medical student textbook, now in fourth edition), Medical Genetics at a Glance (medical student textbook, now in third edition), Emery and Rimoin's Principles and Practice of Medical Genetics (now in 6th edition), and Current Protocols in Human Genetics.
                                                      • Michael F Berger, PhD
                                                        Assistant Professor in the Department of Pathology, Research Scientist, Memorial Sloan-Kettering Cancer Center
                                                        Biography
                                                          Michael Berger, PhD is an Assistant Attending in the Department of Pathology and an Affiliate Member of the Human Oncology and Pathogenesis Program, with expertise in cancer genomics and computational biology. His research focuses on the enumeration of the spectrum of genetic mutations in human tumors in order to identify biomarkers of cancer progression and drug response. Dr. Berger joined the MSKCC faculty in October 2010 after working as a research scientist and computational biologist in the Cancer Program at the Broad Institute of Harvard and MIT. At the Broad, he served as the project leader and primary data analyst for numerous efforts employing massively parallel "next generation" sequencing to characterize genetic mutations in a range of cancers. He now runs an independent research laboratory at MSKCC that is developing methods to reliably and accurately profile clinical specimens for cancer-related DNA mutations and copy number alterations. His laboratory is engaged in many collaborations with clinical and translational investigators to discover significant oncogenic mutations in rare or understudied tumor types and identify genomic biomarkers exhibiting correlations with clinical outcomes and therapeutic response. He is also working closely with the CLIA compliant Diagnostic Molecular Pathology Laboratory to build a robust profiling pipeline and analytical framework for use in real-time patient management. Dr. Berger received his Bachelor's Degree in Physics at Princeton University and his Ph.D. in Biophysics at Harvard University.
                                                        • Michael Snyder, PhD
                                                          Professor and Chair, Genetics, Director, Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine
                                                          Biography
                                                            Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of-the-art "omics" technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of several biotechnology companies, including Protometrix (now part of Life Tehcnologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the board of a number of companies.
                                                          • Christopher I Amos, PhD
                                                            Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
                                                            Biography
                                                              Dr. Amos moved in September, 2012 to the Geisel School of Medicine, where he is leading the Center for Genomic Medicine and serving as the Associate Cancer Center Director for Population Studies. Dr. Amos is leading studies to identify genetic risk factors for lung cancer and melanoma risk using genome-wide association and sequencing approaches. Dr. Amos leads a U19 grant entitled Transdisciplinary Research in Cancer of the Lung (TRICL) to identify genetic factors for lung cancer and interactions with smoking, study these factors in cell biological and animal models and to perform epidemiological studies of gene and environmental contributions to lung cancer risk. This grant includes 16 subcontracts and integrates work from an international consortium. Dr. Amos has served as the leader of the biostatistics core for the Genetic Epidemiology of Lung Cancer Consortium (GELCC) since its inception. With the move to Dartmouth he has replicated the computing environment that manages studies for GELCC and TRICL. Dr. Amos also provides direction for a grant that characterizes and sequences nicotinic receptors and uses fMRI to investigate effects of nicotinic receptor variants on responses to smoking cues. Dr. Amos has also worked extensively in the genetic epidemiology of colon cancer. He developed a Peutz-Jeghers syndrome registry while at M.D. Anderson Cancer Center. He has also studied genetic risk factors for sporadic colon cancer and hereditary nonpolyposis colon cancer. Dr. Amos has developed novel statistical approaches for gene-environment interaction analysis and for the identification of genes influencing complex diseases using either association based approaches or genetic linkage analysis.
                                                            • Linnea Baudhuin, PhD, DABMG
                                                              Co-director, Pharmacogenomics and Genetics Laboratory, Co-director, Cardiovascular Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic
                                                              Biography
                                                                Dr. Baudhuin is Assistant Professor of Laboratory Medicine and Pathology, with a joint appointment in the Department of Medical Genetics, at the Mayo Clinic in Rochester, MN. Dr. Baudhuin is a co-director of molecular genetics, pharmacogenetics, and cardiovascular testing laboratories at the Mayo Clinic. Dr. Baudhuin received her Ph.D. in Clinical Chemistry from Cleveland State University (in conjunction with the Cleveland Clinic) and followed that up with fellowship training in Clinical Chemistry and Clinical Molecular Genetics at the Mayo Clinic. Dr. Baudhuin is board certified in Clinical Molecular Genetics by the American Board of Medical Genetics. Dr. Baudhuin's research interests lie primarily in the areas of cardiovascular-related genetics and pharmacogenetics. Dr. Baudhuin was the recipient of the 2011 Outstanding Scientific Achievements by a Young Investigator (American Association for Clinical Chemistry); the 2010 Clinical Laboratory Sciences Distinguished Author Award (American Society of Clinical Laboratory Science); and the 2006 George Grannis Award for Excellence in Research and Scientific Publication (National Academy of Clinical Biochemistry).
                                                              • Matthew Lebo, PhD, FACMG
                                                                Instructor of Pathology, BWH and Harvard Medical School,  Assistant Laboratory Director and Senior IS Domain Specialist Laboratory for Molecular Medicine, Partners HealthCare Center for Perso
                                                                Biography
                                                                  Matthew Lebo is a trained computational biologist and ABMG-certified clinical molecular geneticist whose work focuses on using statistical and algorithmic approaches to analyze high-throughput data and to bridge genetics with computational and IT systems. Dr. Lebo is currently an Instructor of Pathology at Harvard Medical School and Brigham and Woman's Hospital, where he is developing pipelines to implement whole-genome sequencing data as a clinical test, including methods to analyze, interpret, and report identified genetic variation. Dr. Lebo serves as an Assistant Laboratory Director at the Laboratory for Molecular Medicine (LMM) and as a Senior IS Domain Specialist, both within the Partners Center for Personalized Genetic Medicine (PCPGM). As a director in a clinical diagnostics laboratory, he is responsible for the interpretation and reporting of large gene panel tests - with a special focus in cardiomyopathy - and the development of next-generation sequencing tests, including clinical genome/exome sequencing. As a member of the IT team at PCPGM, Dr. Lebo also works on the development of GeneInsight Suite, an innovative software platform for molecular laboratories, clinics, and EHR systems that manages variant, gene, and disease annotations and the integration of that information into patient reports.
                                                                • George Church, PhD
                                                                  Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School
                                                                  Biography
                                                                    Professor of Genetics, Harvard Medical School, Director of the Center for Computational Genetics. 1984 Harvard PhD included the first direct genomic sequencing method, molecular multiplexing tags, which lead to automation & software used at Genome Therapeutics Corp. for the first commercial genome sequence -- pathogen, Helicobacter in 1994. This multiplex solid-phase sequencing evolved into polonies (1999), ABI-SOLiD (2005) & open-source Polonator.org (2007). Innovations in DNA reading, writing & allele replacement in cells lead to current research & commercialization in human genomics (Complete Genomics, PersonalGenomes.org, 23andme, Knome) , synthetic biology (SynBERC, Joule, LS9) & new ethics/security strategies.
                                                                  • Andrew Hessel, MSc
                                                                    Distinguished Research Scientist, Autodesk Inc., Faculty, Singularity University
                                                                    Biography
                                                                      Autodesk Distinguished Research Andrew Hessel excels at building bridges and catalyzing change. He is a trend-spotter in life science and helps individuals and organizations better understand and prepare for a future of accelerating innovation. He is also the co-founder of the Pink Army Cooperative, the world's first cooperative biotechnology company, which is aiming to produce open source viral therapies for cancer. Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, know as synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He is an advocate of open source genetic engineering and sees DNA technologies growing to resemble the software industry as they continue to evolve. He speaks widely on topics that include cells as living computers, life science as an emerging digital industry, and biological safety and security.
                                                                    • Agnieszka Lichanska, PhD
                                                                      Laboratory Director, TessArae, LLC
                                                                      Biography
                                                                        She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast, University of Queensland and Institute for Molecular Biosciences. Since 2005 until 2008 she held a continuing appointment as a lecturer in a School of Dentistry at the University of Queensland and established her own laboratory in area of functional genomics and metabonomics. She has over 10 years of experience in molecular biology, genetics, genomics, biochemistry, microbiology and metabonomics. In addition she has experience as a science writer. Recently Agnieszka served on the Council of the Australian Society for Biochemistry and Molecular Biology and is still active in the society. Currently she is working on novel diagnostic assays for infectious diseases using microarray re-sequencing technology.
                                                                      • Alisa Jackson, Zach Smith, Mary Blair, Dave Delano
                                                                        Alisa Jackson, Moderator, Beckman Coulter, Inc. Zach Smith, MS, Project Scientist,  The Center for Genomics and Bioinformatics, Indiana University Mary Blair, Senior Application Scientist,
                                                                        Biography
                                                                          Zach Smith serves as the next generation sequencing and laboratory automation specialist at the Center for Genomics and Bioinformatics at Indiana University, Bloomington. His duties include the construction of sequencing libraries for Illumina and Roche 454 sequencing platforms as well as the development of new automation protocols for NGS and genomics research. Mary Blair helps scientists address their automated sample preparation challenges. Mary is responsible for internal development of automated methods for popular Genomic sample preparation kits and protocols on Beckman Coulter's Biomek liquid handling platforms. These fully supported Biomek sample preparation methods are for popular applications such as NGS and qPCR. Fully implemented they yield consistent, quality samples at an increased throughput with decreased labor. Dave Delano manages products in Illumina's gene expression and regulation portfolio including RNA-seq, ChIP-Seq, and methylation applications.
                                                                        • Charles Cantor, PhD
                                                                          Chief Scientific Officer, Sequenom
                                                                          Biography
                                                                            Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals, a drug discovery company, Retrotope, an anti-aging company, and DiThera, a biotherapeutic company. Dr. Cantor is professor emeritus of Biomedical Engineering and of Pharmacology and was the director of the Center for Advanced Biotechnology at Boston University. He is currently adjunct professor of Bioengineering at UC San Diego, adjunct professor of Molecular Biology at the Scripps Institute for Research, and distinguished adjunct professor of Physiology and Biophysics at UC Irvine. Prior to this, Dr. Cantor held positions in Chemistry and then in Genetics and Development at Columbia University and in Molecular Biology at the University of California at Berkeley. Cantor was educated in chemistry at Columbia College (AB) and at the University of California Berkeley (PhD). Dr. Cantor has been granted more than 60 US patents and, with Paul Schimmel, wrote a three-volume textbook on biophysical chemistry. He also co-authored the first textbook on Genomics titled 'The Science and Technology of the Human Genome Project'. In addition, he sits on the advisory boards of numerous national and international biotechnology firms, has published more than 450 peer-reviewed articles, and is a member of the U.S. National Academy of Sciences.
                                                                          • Yaniv Erlich, PhD
                                                                            Principal Investigator, Andria and Paul Heafy Family Fellow, MIT Whitehead Institute for Biomedical Research
                                                                            Biography
                                                                              Dr. Yaniv Erlich is Andria and Paul Heafy Family Fellow and Principal Investigator at the Whitehead Institute for Biomedical Research. He received a bachelor's degree from Tel-Aviv University at Israel and his PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory in 2010. Dr. Erlich's research interests are computational human genetics. His research featured in the New York Times, Wall Street Journal, and NPR. Dr. Erlich is the recipient of the Harold M. Weintraub award, the IEEE/ACM-CS HPC award, Wolf Foundation Scholarship for Excellence in Exact Sciences, and he was selected as one of 2010 Tomorrow's PIs team of Genome Technology.
                                                                            • Jessica C Mar, PhD
                                                                              Assistant Professor, Department of Systems &amp; Computational Biology, Assistant Professor, Department of Epidemiology &amp; Population Health, Albert Einstein College of Medicine
                                                                              Biography
                                                                                Jessica Mar is an Assistant Professor at the Albert Einstein College of Medicine in the Department of Systems and Computational Biology in the Bronx, New York. The Mar lab investigates how variability of gene expression informs our understanding of how genes and pathways are dysregulated in disease. Dr. Mar received her PhD in Biostatistics from Harvard University in 2008. Previously she was a postdoctoral research fellow at the Dana-Farber Cancer Institute in Boston and a visiting scientist at the European Bioinformatics Institute in the United Kingdom. She is a recipient of a University of Queensland medal and an American-Australian Fulbright award. She is currently an Associate Editor of Genomics.
                                                                              • Daniel Caffrey, PhD
                                                                                Assistant Professor at the University of Massachusetts Medical School, Program Chair for the Bioinformatics Program, Instructor in the Rabb School of Continuing Studies, Division of Graduate
                                                                                Biography
                                                                                  Daniel Caffrey is an Assistant Professor in the Department of Medicine at UMASS Medical School. He is also the Program Chair of Bioinformatics at Brandies University. He received his Ph.D from Trinity College Dublin where he studied the evolution and function of the MAP kinase pathways. He completed his postdoctoral training at Pfizer before spending several years there as a Computational Biologist. His current research interests include genome evolution and host-pathogen interactions.
                                                                                • Steven Rosenberg, PhD
                                                                                  Chief Scientific Officer, CardioDx, Inc.
                                                                                  Biography
                                                                                    Steven Rosenberg joined CardioDx in 2006 and is responsible for the scientific staff and for research and development programs in the areas of genomics, genetics, and informatics. In addition, Steven is currently on the Board of Directors of KMT Hepatech. Prior to joining CardioDx, Steven served for three years as the Chief Scientific Officer of XDx, Inc., a molecular diagnostics company focused on diseases of the immune system. He led the group responsible for developing AlloMap, a molecular diagnostic for heart transplant patients, the first genomics-based test in transplant immunology. Prior to XDx, Steven spent a year as a consultant and visiting scholar at the University of California, Berkeley. From 1981 to 2001 he was at Chiron Corporation, where he was named one of only three Chiron Research Fellows in the company's history. He received his Ph.D. in biochemistry from the University of California, Berkeley, and is the author of more than 40 scientific publications, and an inventor of more than 20 U.S. patents.
                                                                                  • Patrice Milos, PhD
                                                                                    Chief Executive Officer, Claritas Genomics
                                                                                    Biography
                                                                                      Dr. Milos recently joined Claritas Genomics, a newly formed company focused on pediatric molecular diagnostics emerging from Boston Children's Hospital in partnership with Life Technologies. Claritas Genomics combines the power of next-generation DNA sequencing technology with the clinical expertise of the world's best pediatric specialists to inform and improve patient care. Patrice most recently served as the Boston Site Head for Pfizer's Centers of Therapeutic Innovation and Precision Medicine Lead. The CTI model represented a new and exciting approach to drug discovery through establishment of academic medical center partnerships, including Beth Israel, Boston Children's Hospital, Tufts Medical Center, Boston University School of Medicine and Partners Healthcare, along with Pfizer to establish proof of mechanism for novel targets and pathways aiming to treat human disease. Dr. Milos previously served as the Senior Vice President and Chief Scientific Officer for Helicos BioSciences Corporation, Cambridge, MA joining in June 2007. Her expertise and extensive knowledge in the life sciences helped advance the company's efforts to develop and apply innovative and breakthrough single molecule DNA and RNA sequencing technology with recent focus on molecular diagnostics. Accomplishments included the development of the world's first and only method for direct capture and sequencing of BRCA1/2, the only method for direct sequencing of RNA as well as the establishment of collaborations with world class institutions including the Broad Institute, Harvard Medical School, Massachusetts General Hospital and the Children's Oncology Group. Patrice's previously served as Executive Director for Pfizer Global Research and Development, Groton, CT. Patrice was responsible for leadership, strategy alignment and execution of the scientific disciplines of pharmacogenomics, proteomics, metabonomics and RNA profiling applied across the Pfizer portfolio from early discovery into the marketplace. Initially joining Pfizer in 1993, Dr. Milos held numerous research positions of increasing responsibility focusing on Cardiovascular and Metabolic Disease, Pharmacogenomics, DNA Sequencing, Biomarkers and Molecular Sciences. Dr. Milos serves on the Boston Children's Hospital Technology Advisory Board, is an active NIH grant reviewer and has served on the National Advisory Council for Human Genome Research. Patrice was also pivotal in the establishment and oversight of key Pfizer strategic investments in the genomics area, most notably, the Genetic Association Information Network in partnership with NIH. She also sits on several journal editorial boards and has published and presented extensively in genomic sciences. Dr. Milos conducted post-doctoral fellowships at Brown University and Harvard University. She earned her MS and PhD degrees at Rensselaer Polytechnic Institute in Troy, NY.
                                                                                    • Nir Barzilai, MD
                                                                                      Director, Institute for Aging Research, Ingeborg and Ira Leon Rennert Chair in Aging Research, Professor, Department of Medicine (Endocrinology), Professor, Department of Genetics, Albert Ein
                                                                                      Biography
                                                                                        Dr. Barzilai is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Glenn Center for the Biology of Human Aging and of the Nathan Shock Center of excellence in biology of aging. He is The Ingeborg and Ira Leon Rennert Professor of Aging Research, Professor of Medicine and Molecular Genetics and a member of the Diabetes Research Center, the Divisions of Endocrinology and Geriatrics. Dr. Barzilai's interests focus on several basic mechanisms in the biology of aging, including the biological effects of nutrients on extending life and the genetic determinants of life span. Indeed, he has discovered longevity genes in humans, and is further characterizing the phenotype and genotype of humans with exceptional longevity through an NIH supported Program Project. He received numerous grants, among them ones from the National Institute of Aging (NIA), American Federation of Aging Research, and the Ellison Medical Foundation. Dr. Barzilai has published over 200 peer-reviewed papers, reviews and chapters in textbooks. He is an advisor to the National Institutes of Health on several projects and initiatives and study sections (currently on NIA-Biology). He serves on several editorial boards and is a reviewer for numerous other journals. Dr. Barzilai was a recipient of numerous prestigious awards, including the Beeson Fellow for Aging Research, the Senior Ellison Foundation award, the Paul Glenn Foundation award and the NIA- Nathan Shock Award and the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research Award.
                                                                                      • Nathan R Treff, PhD
                                                                                        Director of Molecular BiologyResearch, Reproductive Medicine Associatesof New Jersey, Associate Professor, Department of Obstetrics, Gynecology,and Reproductive Sciences, UMDNJ-Robert Wood Jo
                                                                                        Biography
                                                                                          Dr. Nathan Treff serves as Director of Molecular Biology Research at RMA of New Jersey, Associate Professor at the Robert Wood Johnson Medical School, and Adjunct Professor at Rutgers University. Dr. Treff's laboratory uses molecular genetics to discover, develop, and translate novel molecular diagnostics to improve the quality of life for patients with infertility and has published more on the use of arrays in preimplantation aneuploidy screening than any other group in the world. His research was awarded the 2007 and 2010 General Program Prize and the 2009 and 2010 Society for Assisted Reproductive Technology Prize by the American Society for Reproductive Medicine. He completed his Ph.D. in biochemistry at Washington State University where he earned the Charles Glenn King Scholarship and the National Institutes of Health Predoctoral Fellowship in protein biotechnology. Dr. Treff trained as a postdoctoral fellow in stem cell biology at the University of Wisconsin-Madison, and in reproductive biology at the EMD-Serono Research Institute.
                                                                                        • Bruce K Patterson, MD
                                                                                          CEO and Founder, IncellDx Inc
                                                                                          Biography
                                                                                            Dr. Patterson received his undergraduate training in molecular biology from the University of Michigan in Ann Arbor. He then went on to Northwestern University Medical School for training in medicine. During the early stages of the AIDS epidemic, Dr. Patterson began investigating cellular reservoirs of HIV-1 using molecular and in situ technology patented in his laboratory. Dr. Patterson went on to a residency in Pathology focusing on viral pathogenesis. While in his residency, Dr. Patterson determined that enough HIV virus was present in infected individuals to account for the massive destruction of the immune system. This paradigm altering work was published in Science in 1993. Dr. Patterson later was named Chief Resident of Pathology at Northwestern Memorial Hospital. Dr. Patterson has authored over 100 manuscripts and book chapters and he continues his work on HIV-1 pathogenesis and reservoirs at Stanford University School of Medicine. Dr. Patterson was the Medical Director of Diagnostic Virology at Stanford University Hospitals and Clinics.
                                                                                          • Vincent P Mauro, PhD
                                                                                            Associate Professor of Neurobiology, Scripps Institute
                                                                                            Biography
                                                                                              Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr. Mauro is a Senior Fellow in Experimental Neurobiology at the Neurosciences Institute in San Diego, California. Prior to moving to The Scripps Research Institute, Dr. Mauro received his Ph.D. at McGill University in Montreal, Quebec, and continued his studies as a postdoctoral fellow at The Rockefeller University in New York City. Dr. Mauro studies both fundamental and applied aspects of translational control mechanisms. His basic research is focused on understanding how eukaryotic mRNAs recruit ribosomes, how ribosomes subsequently locate initiation codons, and how ribosomes regulate the translation of specific subsets of mRNAs. Dr. Mauro's applied studies build on his basic research. These applied studies have led to the identification of Translational Enhancer Elements (TEEs) and the generation of synthetic translational enhancers.
                                                                                            • Kimberly Strong, PhD
                                                                                              Assistant Professor, Primary Faculty for the Program in Genomics and Ethics, Medical College of Wisconsin
                                                                                              Biography
                                                                                                Kimberly Strong, PhD is the primary faculty with the Program in Genomics and Ethics at the Medical College of Wisconsin's Center for Bioethics and Medical Humanities and she also holds a secondary appointment with the MCW Human and Molecular Genetics Center. She has degrees in Biology, Genetic Counseling, and Bioethics and has direct experience in preimplantation genetic diagnosis, embryology, genetic counseling, psychosocial research, patient advocacy and research ethics and her lectures have included bioethical issues related to assisted reproductive technologies, gamete donation, genetic counseling, genetic testing and stem cell research. Dr. Strong's broad academic area of expertise is in the application and limits of 'empirical bioethics', particularly its value in informing the discourses surrounding contentious and emerging technologies. Her current research revolves around exploring the ethical and social issues involved in the use of whole genome sequencing.
                                                                                              • Robert Roberts, MD, FRCPC, MACC, LLD (Hon.)
                                                                                                President, Chief Executive Officer and Chief Scientific Officer, Professor of Medicine, Director, Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute
                                                                                                Biography
                                                                                                  Robert Roberts is the President and CEO of the University of Ottawa Heart Institute and founding Director of The Ruddy Canadian Cardiovascular Genetics Centre. He received his M.D. from Dalhousie University and completed his residency in Internal Medicine and Fellowship in Cardiology at the University of Toronto. Funded by a Canadian Heart Foundation Scholarship, he pursued research in heart disease and in 1982 became Chief of Cardiology at Baylor College of Medicine in Houston, Texas. As a cardiologist, educator and scientist, he developed the MCBK Test which has been used to diagnose heart attacks for the past three decades. Dr. Roberts' research led him to molecular biology and genetics, during which time he discovered many genes responsible for heart disease. Dr. Roberts is generally regarded as one of the founders of molecular cardiology. Dr Roberts has had a distinguished and prolific career as a Cardiologist, Educator and Scientist having published over 850 scientific articles and received many awards including the 2012 Research Achievement Award from the Canadian Cardiovascular Society; the 2012 Distinguished Fellowship Award from the International Academy of Cardiology; the McLaughlin Medal from the Royal Society of Canada and the Albrecht Fleckenstein Memorial Award from the International Academy of Cardiology in 2008; Citation for Highly Cited Researcher from ISI Thomson Scientific in 2002; and the Distinguished Scientist Award from the American College of Cardiology in 1998.
                                                                                                • David F Keren, MD
                                                                                                  Professor, Department of Pathology, Associate Director, Clinical Pathology Laboratories, University of Michigan Health System
                                                                                                  Biography
                                                                                                    Dr. Keren received his B.S., M.S. and M.D. degrees from the University of Illinois, the latter in 1971. He completed his residency training in Anatomic and Clinical Pathology and postdoctoral training in Immunopathology and Immunohematology at The Johns Hopkins Hospital from 1971-1976. From 1976-1978 he served as a Major in the United States Armed Forces at the Walter Reed Army Institute for Research in Washington, D.C. He joined the Department of Pathology of the University of Michigan in 1978. From 1989 through 2011 he served as the Medical Director of Warde Medical Laboratory while continuing as an Adjunct Clinical Professor of Pathology at the University of Michigan. Dr. Keren has authored over 160 peer-reviewed articles and has written or edited 13 books. He has received several awards including the Carl A. Jolliff Award from the Clinical and Diagnostic Immunology Division of the American Association of Clinical Chemists, a Lifetime Achievement Award from the Michigan Society of Pathologists, the Israel Davidsohn Award, the Distinguished Service Award, and the Mastership Award from the American Society for Clinical Pathology. Dr. Keren served as the President of the Gastrointestinal Pathology Society (1993), President of the Michigan Society of Pathologists (2000), President of the American Society for Clinical Pathology (2003), and President of the American Board of Pathology (2011). Currently, he is a Trustee of the American Board of Pathology and a member of the CAP Hematology and Clinical Microscopy Resource Committee.
                                                                                                  Sponsored By

                                                                                                  For information on becoming a sponsor or exhibitor, please click here.


                                                                                                  Continuing Education (CME/CE/CEU) Credits

                                                                                                  The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                                                                  Help

                                                                                                  General LabRoots Questions

                                                                                                  For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                                                                  Contact us

                                                                                                  Virtual Events and Webinars

                                                                                                  Supported Configurations

                                                                                                  • Operating System Internet Explorer Firefox Chrome Safari
                                                                                                    Vista IE8+ FF10+ Chrome15+
                                                                                                    Windows 7 IE8+ FF10+ Chrome15+
                                                                                                    Windows 8 IE10 FF10+ Chrome15+
                                                                                                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                                                                  • Cookie settings: session cookies enabled
                                                                                                  • Browser configuration must have JavaScript enabled
                                                                                                  • Adobe Flash player 10.2 or later

                                                                                                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                                                                  Internet Connection

                                                                                                  • A minimum of 100Kbps is recommended for audio-only events
                                                                                                  • A minimum of 300Kbps is recommended for speaker on-video events

                                                                                                  Computer Equipment

                                                                                                  • Screen Resolution: Minimum 1024x768
                                                                                                  • Video Card: 65,000 colors minimum
                                                                                                  • Sound card and speakers (or headphones) for hearing webcast in full format
                                                                                                  • Audio Card: 16-bit minimum
                                                                                                  • RAM: 512MB of free RAM

                                                                                                  Firewall Protocol

                                                                                                  • HTTP on port 80 or HTTPS on port 443
                                                                                                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                                                                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                                                                  Work-At-Home Attendees

                                                                                                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                                                                  For A Seamless Experience

                                                                                                  When using a mobile device, FREE Mobile Apps are available:

                                                                                                  - For viewing Webinars:

                                                                                                  - For viewing Virtual Events

                                                                                                  Attendee Guide

                                                                                                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                                                                  Virtual Event and Webinar Support:

                                                                                                  Continuing Education (CME/CE) Support

                                                                                                  Loading Comments...
                                                                                                  Show Resources